CountryDE, FR, IT
CallJTC 2017

ROCSANbio

Anti-PD1 and Niraparib (PARPi) combination therapy in gynae carcinosarcoma: Identification of response-predictive biomarkers and resistance mechanisms

Project Coordinator 

  • Isabelle Ray-Coquard
    • Centre Léon Bérard, Department of Medical Oncology
    • Lyon - France

Project Partners 

  • Marc-Henri Stern
    • Institut Curie, Centre de Recherche, Insert U830
    • Paris - France
  • Elena Ioana Braicu
    • Charité Medizinische Universität - Department of Gynecology
    • Berlin - Germany
  • Sandro Pignata
    • Istituto Nazionale Tumori di Napoli "Fondazione G. Pascale” IRCSS
    • Naples - Italy